Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-19

Clinical Trial Update: Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial examining varenicline's effects on alcohol reactivity in participants with alcohol use disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: Yale University | Conditions: Alcohol Reactivity | Phase 2 | Status: COMPLETED | Results posted: 2018-02-19